Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Metagenomi Therapeutics, Inc. shareholders
As of Jun 30, 2026, 40 institutions reported holding Metagenomi Therapeutics, Inc., 16.6% of its shares. Largest: Vanguard, Renaissance Technologies and Catalio Capital Management, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Metagenomi Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 1.26M | 3.3% | +20,833 | Aug 13, 2026 |
| Renaissance Technologies | 742K | 2.0% | −45,500 | Aug 13, 2026 |
| Catalio Capital Management, LP | 529K | 1.4% | no change | Aug 14, 2026 |
| Two Sigma | 529K | 1.4% | +32,107 | Aug 14, 2026 |
| Peapod Lane Capital LLC | 525K | 1.4% | +8,263 | Jul 27, 2026 |
| Bridgeway Capital Management, LLC | 400K | 1.1% | +4,500 | Aug 14, 2026 |
| Wells Fargo | 380K | 1.0% | +177K | Aug 14, 2026 |
| Geode Capital | 289K | 0.76% | −69,535 | Aug 12, 2026 |
| Pura Vida Investments, LLC | 264K | 0.70% | no change | Aug 13, 2026 |
| BlackRock | 258K | 0.68% | +27,497 | Aug 7, 2026 |